Jeffrey W. Ubben - Feb 16, 2023 Form 4 Insider Report for Enviva Inc. (EVA)

Role
Director
Signature
/s/ Jeffrey W. Ubben
Stock symbol
EVA
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
4
Date filed
2/21/2023, 03:51 PM
Previous filing
Feb 2, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVA Common Stock Award $0 +683 +9.31% $0.00 8.02K Feb 16, 2023 Direct F1, F2
holding EVA Common Stock 5.74M Feb 16, 2023 See footnotes F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
F2 The Reporting Person is deemed to hold the shares of Common Stock for the benefit of certain funds (the "In-Cap Funds") managed by Inclusive Capital Partners, L.P. ("In-Cap") and indirectly for the benefit of In-Cap, and may, after vesting, if applicable, transfer the shares of Common Stock directly to the In-Cap Funds.
F3 The securities reported herein are held by the In-Cap Funds to which In-Cap acts as investment manager. The Reporting Person indirectly controls In-Cap.

Remarks:

In-Cap may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that the Reporting Person currently serves on the board of directors of the Issuer. Eva Zlotnicka, a Founder and Managing Partner at In-Cap, also serves on the board of directors of the Issuer. Ms. Zlotnicka has separately filed a Form 4 to report an award which she holds for the benefit of In-Cap and the In-Cap Funds.